ANEW - ETF AI Analysis
Top Page
ProShares MSCI Transformational Changes ETF (ANEW)
Rating:64Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors like health care, technology, communication services, and consumer stocks, which helps reduce the impact if one industry struggles.
Solid Recent Performance
The fund has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.
Strong Health Care and Tech Leaders
Several top holdings in health care and technology, such as Eli Lilly, AbbVie, Apple, and others, have delivered strong year-to-date performance that supports the fund’s returns.
Negative Factors
Small Asset Base
The ETF manages a relatively low amount of assets, which can make it more vulnerable to large investor inflows or outflows and potentially higher trading spreads.
Mixed Performance Among Top Holdings
Some of the largest positions, including DoorDash, Abbott Laboratories, McCormick, and Meta Platforms, have shown weak year-to-date performance, which can drag on overall results.
Heavy U.S. Concentration
With most of its holdings in U.S. companies, the fund is heavily tied to the U.S. market and offers limited protection if that market faces a downturn.
ANEW vs. SPDR S&P 500 ETF (SPY)
AUM8.07M
RegionGlobal
Expense Ratio0.45%
Beta0.94
IssuerProShares
Inception DateOct 14, 2020
Dividend Yield0.51%
Asset ClassEquity
Index TrackedMSCI Global Transformational Changes Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume187
30 Day Avg. Volume187
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
62.46Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering139
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ANEW Summary
ANEW is an ETF that follows the MSCI Global Transformational Changes Index, focusing on big long-term themes like new technology, aging populations, and environmental change. It holds a mix of health care, technology, and communication companies from around the world, including well-known names like Apple and Meta Platforms, as well as major drug makers such as AbbVie and Eli Lilly. Someone might invest in ANEW to get diversified exposure to companies driving future growth and innovation in many industries at once. A key risk is that these growth-focused stocks can be volatile and may go up and down sharply with market conditions.
How much will it cost me?The ProShares MSCI Transformational Changes ETF (Ticker: ANEW) has an expense ratio of 0.45%, which means you’ll pay $4.50 per year for every $1,000 invested. This expense ratio is slightly higher than average because the fund is actively managed to focus on companies driving transformational changes across industries, requiring more research and specialized management.
What would affect this ETF?The ANEW ETF could benefit from continued advancements in technology, healthcare innovation, and global adoption of clean energy solutions, as these sectors are heavily represented in its holdings. However, it may face challenges from rising interest rates, which can impact growth-focused companies, and regulatory changes in key markets like China, where some top holdings are based. Global economic uncertainty could also affect consumer spending and corporate investments in transformational industries.
ANEW Top 10 Holdings
ANEW leans heavily into health care and innovation, with AbbVie and Eli Lilly acting as steady engines of long-term growth, even if their recent moves have been more measured than explosive. Abbott and Danaher, both key health care names, have been more mixed, with earlier strength now bumping into some short-term headwinds. Outside the lab, Apple is rising and helps anchor the fund’s tech exposure, while DoorDash has been lagging and quietly dragging on returns. With a global mix of holdings, ANEW is clearly betting on transformational change across borders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| DoorDash | 2.54% | $205.66K | $93.71B | -18.05% | 76 Outperform | |
| Danaher | 2.35% | $189.90K | $143.94B | 4.81% | 75 Outperform | |
| Abbott Laboratories | 2.29% | $185.31K | $186.55B | -17.31% | 73 Outperform | |
| Microsoft | 2.27% | $183.70K | $3.71T | -3.01% | 79 Outperform | |
| Eli Lilly & Co | 2.25% | $182.33K | $1.12T | 93.94% | 72 Outperform | |
| Symrise | 2.24% | $181.36K | €12.85B | 15.98% | 63 Neutral | |
| Givaudan SA | 2.22% | $179.29K | CHF31.09B | 0.45% | 69 Neutral | |
| International Flavors & Fragrances | 2.21% | $179.03K | $21.91B | 34.08% | 61 Neutral | |
| AbbVie | 2.17% | $175.81K | $434.78B | 24.83% | 66 Neutral | |
| McCormick & Company | 2.11% | $170.33K | $14.24B | -23.74% | 73 Outperform |
ANEW Technical Analysis
Positive
―
Price Trends
51.35
Positive
49.69
Positive
49.81
Positive
Market Momentum
0.67
Negative
68.90
Neutral
98.98
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ANEW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 51.93, equal to the 50-day MA of 51.35, and equal to the 200-day MA of 49.81, indicating a bullish trend. The MACD of 0.67 indicates Negative momentum. The RSI at 68.90 is Neutral, neither overbought nor oversold. The STOCH value of 98.98 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ANEW.
ANEW Peer Comparison
Comparison Results
Performance Comparison
ANEW
ProShares MSCI Transformational Changes ETF
53.72
3.59
7.16%
CSNR
Cohen & Steers Natural Resources Active ETF
―
―
―
SOCL
Global X Social Media ETF
―
―
―
FITZ
Fitz-Gerald Must Have Portfolio ETF
―
―
―
NXTE
AXS Green Alpha ETF
―
―
―
DARP
Grizzle Growth Etf
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents